Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium-Reference-Cited by-同舟云学术

Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium

Published:2010-02 Issue:3 Volume:105 Page:317-321
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Petrylak Daniel P.,Tangen Catherine M.,Van Veldhuizen Peter J.,Goodwin J. Wendall,Twardowski Przemyslaw W.,Atkins James N.,Kakhil Shaker R.,Lange Marianne K.,Mansukhani Mahesh,Crawford E. David

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2009.08799.x/fullpdf

Reference16 articles.

1. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Saxman;J Clin Oncol,1997

2. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005

3. Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma;McCaffrey;J Clin Oncol,1997

4. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma;Galsky;Invest New Drugs,2007

5. 5 Gallucci M , Merola R , Leonardo C , Ruggeri EM , Cianciulli AM . Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases. BJU Int 2005; 96: 440

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Neoadjuvant Chemotherapy in Advanced Bladder Cancer;annals of urologic oncology;2024-08-20

2. Developing Precision Medicine for Bladder Cancer;Hematology/Oncology Clinics of North America;2021-06

3. Novel Tyrosine Kinase Targets in Urothelial Carcinoma;International Journal of Molecular Sciences;2021-01-13

4. The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer;Cell Reports Medicine;2020-10

5. EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer;Oncogene;2020-09-25